4-iodo-2-5-dimethoxy-beta-phenethylamine and Serotonin-Syndrome

4-iodo-2-5-dimethoxy-beta-phenethylamine has been researched along with Serotonin-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for 4-iodo-2-5-dimethoxy-beta-phenethylamine and Serotonin-Syndrome

ArticleYear
Recurrent seizures and serotonin syndrome following "2C-I" ingestion.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2013, Volume: 9, Issue:2

    The phenethylamines, including 2, 5 dimethoxy-4-iodophenethylamine, commonly referred to as 2C-I, have recently emerged as a new class of designer drugs. Cases of toxicity from these drugs are not well described in the literature. This case report describes a 19 year-old male who insufflated 2C-I. Following the ingestion, the patient developed recurrent seizures, and was taken to the emergency department, where he was noted to be hyperadrenergic and had recurrent seizures. The patient was diagnosed with serotonin syndrome and experienced prolonged respiratory failure, although he ultimately made a full recovery. Comprehensive drug testing revealed the presence of 2C-I. The pharmacologic properties of 2C-I are also discussed.

    Topics: Adult; Designer Drugs; Dimethoxyphenylethylamine; Emergency Service, Hospital; Humans; Insufflation; Male; Phenethylamines; Respiratory Insufficiency; Seizures; Serotonin Syndrome; Substance-Related Disorders; Treatment Outcome; Young Adult

2013